Bengaluru based Strides Arcolab, an Indian drug manufacturer, has expanded its portfolio of offerings by acquiring brands from two companies in separate transactions. Strides signed a deal with Johnson & Johnson to buy seven of its brands in the dermatology, antiemetic and pain management segments. The portfolio acquired from J&J includes Otogesic eardrops, Ehnorub ointment and Stugil tablets. In a separate transaction, Strides will acquire a majority stake in the domestic branded businesses of Medispan, part of the Chennai-based Shriram Group, with a presence in probiotic, nutritional, anti-infective and gastrointestinal drugs. The brands that Strides will gain from Medispan include Lactovit and Lactogut. The deal value of the transaction was not disclosed.

(Economic Times)